| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |